Clinical Trials Directory

Trials / Completed

CompletedNCT00856414

Patient Satisfaction With Treatment of BOTOX® Cosmetic for the Temporary Correction of Moderate to Severe Glabellar Lines

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
45 (actual)
Sponsor
Allergan · Industry
Sex
Female
Age
35 Years – 55 Years
Healthy volunteers
Not accepted

Summary

This study evaluates the patient satisfaction and onset of effect following treatment with botulinum toxin Type A in the treatment of glabellar rhytids (frown lines)

Conditions

Interventions

TypeNameDescription
BIOLOGICALbotulinum toxin Type A20U, up to two injections administered intramuscularly into the glabella (2 in each side of the corrugators and 1 in the procerus)

Timeline

Start date
2009-03-01
Primary completion
2009-04-01
Completion
2009-04-01
First posted
2009-03-05
Last updated
2019-01-29
Results posted
2011-12-12

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT00856414. Inclusion in this directory is not an endorsement.